Dadra and Nagar Haveli, Chandigarh, Himachal Pradesh, Andaman and Nicobar Islands, Uttarakhand, Daman and Diu, Lakshadweep, Gujarat, , South India, North India, East India, Andhra Pradesh, Assam, Arunachal Pradesh, Nagaland, Goa, Haryana, Jammu and Kashmir, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Mizoram, Meghalaya, Manipur, Punjab, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Tripura, West Bengal, Bihar, Odisha, Chhattisgarh, Maharashtra, Delhi, Uttar Pradesh, Telangana, Central India, West India, All India
Product Description
TAFFIC is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for Hiv